The local subsidiary of the company “Seegene MIDDLE EAST” said on 16 May (local time), having signed the exclusive source agreement with the Kuwaiti Ministry of Health. The source agreement is the largest volume purchased through Kuwait’s government since Seegene began offering diagnostics The agreement implies that South Korean biotechnology company Seegene has the advantage over its global competitors, given that the Kuwaiti government had gained diagnostic tests from one of the world’s molecular diagnostic corporations until last year.
Under this agreement, Seegene MIDDLE EAST will supply allplexTM SARS-CoV-2 control to five Ministry of Health laboratories for the five-month birth in May. The $4. 8 million deal is worth six to seven times more than the company’s previous exports to Kuwait in the although the number of COVID-19 cases in the country showed a downward trend at birth of the year thanks to the state mass vaccination program it initiated last December, there has been a resurgence of infections due to the emergence of variants of COVID-19 Array According to Worldometer , on 17 May, Kuwait reported 828 new cases of COVID-19, bringing the total number of infections in the country to 291,629.